RHUMBLINE ADVISERS - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,027,698
-9.1%
80,795
+0.6%
0.00%0.0%
Q2 2023$1,131,130
+94634.5%
80,336
+4.0%
0.00%0.0%
Q1 2023$1,194
+8.1%
77,256
+14.6%
0.00%0.0%
Q4 2022$1,105
-99.9%
67,426
+3.2%
0.00%
-50.0%
Q3 2022$1,209,000
+51.5%
65,356
+7.7%
0.00%
+100.0%
Q2 2022$798,000
+97.0%
60,668
+38.9%
0.00%0.0%
Q1 2022$405,000
-4.3%
43,682
+1.0%
0.00%0.0%
Q4 2021$423,000
-71.9%
43,268
-2.3%
0.00%
-50.0%
Q3 2021$1,505,000
-4.6%
44,303
+2.8%
0.00%0.0%
Q2 2021$1,577,000
-19.6%
43,076
-1.5%
0.00%
-33.3%
Q1 2021$1,962,000
-27.8%
43,754
-8.1%
0.00%
-25.0%
Q4 2020$2,716,000
+13.3%
47,589
+1.8%
0.00%0.0%
Q3 2020$2,398,000
-29.9%
46,748
-18.4%
0.00%
-33.3%
Q2 2020$3,422,000
+188.5%
57,308
+99.0%
0.01%
+200.0%
Q1 2020$1,186,000
-27.4%
28,801
+9.8%
0.00%
-33.3%
Q4 2019$1,633,000
+114.0%
26,232
+16.6%
0.00%
+200.0%
Q3 2019$763,000
+108.5%
22,493
+38.4%
0.00%0.0%
Q2 2019$366,000
+39.2%
16,248
+43.3%
0.00%0.0%
Q1 2019$263,000
+9.1%
11,341
-1.1%
0.00%0.0%
Q4 2018$241,000
-16.6%
11,466
+53.6%
0.00%0.0%
Q3 2018$289,000
-4.0%
7,466
-2.3%
0.00%0.0%
Q2 2018$301,0007,6410.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders